Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley Marks

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
BMC Health Services Research|March 28, 2018
Implementation of surgical debriefing programs in large health systems: an exploratory qualitative analysisMary E Brindle, Natalie Henrich, Andrew Foster, et al.
Journal of the American College of Surgeons|March 2, 2015
Using value-based analysis to influence outcomes in complex surgical systemsJohn R Kirkpatrick, Stanley Marks, Michele Slane, et al.
Future Oncology (London, England)|November 16, 2021
Real-world ibrutinib dose reductions, holds and discontinuations in chronic lymphocytic leukemiaJing-Zhou Hou, Kellie Ryan, Senxi Du, et al.
Blood|March 31, 2012
Long-term results of chemoimmunotherapy with low-dose fludarabine, cyclophosphamide and high-dose rituximab as initial treatment for patients with chronic lymphocytic leukemiaKenneth A Foon, Dhaval Mehta, Suzanne Lentzsch, et al.
Journal of Cutaneous Pathology|October 11, 2015
Langerhans cell histiocytosis and Erdheim-Chester disease, both with cutaneous presentations, and papillary thyroid carcinoma all harboring the BRAF(V600E) mutationWilliam T Johnson, Parth Patel, Amanda Hernandez, et al.
Stem Cells (Dayton, Ohio)|September 28, 2002
Differentiation of immunostimulatory stem-cell- and monocyte-derived dendritic cells involves maturation of intracellular compartments responsible for antigen presentation and secretionSvetlana N Bykovskaia, Galina V Shurin, Scott Graner, et al.
Oncology Research|March 3, 2016
Flow Cytometric Evaluation of Double/Triple Hit LymphomaChristine G Roth, Amanda Gillespie-Twardy, Stanley Marks, et al.
European Journal of Haematology|March 19, 2015
Outcome of acute myeloid leukemia patients with pulmonary nodules of uncertain etiology receiving allogeneic hematopoietic progenitor cell transplantSara J Lim, Matthew J Lim, Anastasios Raptis, et al.
American Journal of Hematology|December 15, 2015
Peri-transplant clostridium difficile infections in patients undergoing allogeneic hematopoietic progenitor cell transplantAya Agha, Alison Sehgal, Matthew J Lim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Chemoimmunotherapy with low-dose fludarabine and cyclophosphamide and high dose rituximab in previously untreated patients with chronic lymphocytic leukemiaKenneth A Foon, Michael Boyiadzis, Stephanie R Land, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
BMC Health Services Research|March 28, 2018
Implementation of surgical debriefing programs in large health systems: an exploratory qualitative analysisMary E Brindle, Natalie Henrich, Andrew Foster, et al.
Journal of the American College of Surgeons|March 2, 2015
Using value-based analysis to influence outcomes in complex surgical systemsJohn R Kirkpatrick, Stanley Marks, Michele Slane, et al.
Future Oncology (London, England)|November 16, 2021
Real-world ibrutinib dose reductions, holds and discontinuations in chronic lymphocytic leukemiaJing-Zhou Hou, Kellie Ryan, Senxi Du, et al.
Blood|March 31, 2012
Long-term results of chemoimmunotherapy with low-dose fludarabine, cyclophosphamide and high-dose rituximab as initial treatment for patients with chronic lymphocytic leukemiaKenneth A Foon, Dhaval Mehta, Suzanne Lentzsch, et al.
Journal of Cutaneous Pathology|October 11, 2015
Langerhans cell histiocytosis and Erdheim-Chester disease, both with cutaneous presentations, and papillary thyroid carcinoma all harboring the BRAF(V600E) mutationWilliam T Johnson, Parth Patel, Amanda Hernandez, et al.
Stem Cells (Dayton, Ohio)|September 28, 2002
Differentiation of immunostimulatory stem-cell- and monocyte-derived dendritic cells involves maturation of intracellular compartments responsible for antigen presentation and secretionSvetlana N Bykovskaia, Galina V Shurin, Scott Graner, et al.
Oncology Research|March 3, 2016
Flow Cytometric Evaluation of Double/Triple Hit LymphomaChristine G Roth, Amanda Gillespie-Twardy, Stanley Marks, et al.
European Journal of Haematology|March 19, 2015
Outcome of acute myeloid leukemia patients with pulmonary nodules of uncertain etiology receiving allogeneic hematopoietic progenitor cell transplantSara J Lim, Matthew J Lim, Anastasios Raptis, et al.
American Journal of Hematology|December 15, 2015
Peri-transplant clostridium difficile infections in patients undergoing allogeneic hematopoietic progenitor cell transplantAya Agha, Alison Sehgal, Matthew J Lim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Chemoimmunotherapy with low-dose fludarabine and cyclophosphamide and high dose rituximab in previously untreated patients with chronic lymphocytic leukemiaKenneth A Foon, Michael Boyiadzis, Stephanie R Land, et al.
Pageof 2